Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test MLPA- IKZF1 & CDKN2A Deletion/Duplication Analysis Test is typically 14-21 days after the sample is received by the laboratory.

What are the prerequisites for the test MLPA- IKZF1 & CDKN2A Deletion/Duplication Analysis Test

  • Specimen Type: Whole blood, bone marrow, or extracted DNA
  • Specimen Container: Lavender top (EDTA) tube, yellow top (ACD) tube, or purple top (EDTA) tube for DNA
  • Specimen Volume: 3-5 mL whole blood or bone marrow, 10-20 µg DNA
  • Specimen Storage: Refrigerate whole blood or bone marrow, store DNA at -20°C
  • Shipping Conditions: Ship whole blood or bone marrow at room temperature, ship DNA on dry ice
  • Turnaround Time: 14 days

What are the measure values for the test MLPA- IKZF1 & CDKN2A Deletion/Duplication Analysis Test

  • Test Name: MLPA- IKZF1 & CDKN2A Deletion/Duplication Analysis Test
  • Measure Values:
    • Deletion: Present/Not Present
    • Duplication: Present/Not Present

What does this test MLPA- IKZF1 & CDKN2A Deletion/Duplication Analysis Test identify?

  • MLPA- IKZF1 & CDKN2A Deletion/Duplication Analysis Test identifies deletions or duplications in the IKZF1 and CDKN2A genes.
  • Deletions or duplications in these genes are associated with various types of cancer, including acute lymphoblastic leukemia (ALL) and melanoma.
  • This test helps in determining the genetic predisposition to cancer and can aid in personalized treatment and management strategies.
  • Results from this test can also provide information about the risk of cancer recurrence and guide decisions regarding surveillance and preventive measures.

Why is this test MLPA- IKZF1 & CDKN2A Deletion/Duplication Analysis Test taken?

MLPA- IKZF1 & CDKN2A Deletion/Duplication Analysis Test is taken to detect any deletions or duplications in the IKZF1 and CDKN2A genes. These genes are associated with certain types of cancer, including leukemia and lymphoma. By analyzing these genes, doctors can determine if a person is at an increased risk for developing these types of cancer.

No FAQs available.

Customer Google Rating